A 12-week intervention combining breathing exercises, cold exposure, and meditation — known as the Wim Hof Method (WHM) — or a lifestyle intervention aimed at improving physical activity and dietary habits may help reduce inflammation linked to disease progression in people with multiple sclerosis (MS),…
Tweet This study looks at anti-drug antibodies against natalizumab and suggests that loss of efficacy is one of the better predictors of the response, but suggests that looking for ADA after a suspicious event is better than routine testing. They did this study because of…
Tweet I guess this blog is about celebrating research, but sadly research is a loser today and it comes with great sadness to report the passing of ProfAngry (1960-2026) who has been one of our research buddies for many years. Angray Kang was a Professor…
In multiple sclerosis (MS), certain disease-driving immune cells carry a protein marker called CD29, which helps them move into the brain and trigger inflammation. That is the key finding of a new study by researchers in the Netherlands, who zeroed in on the protein as…
Tweet The post below has very little to do with the title of my post but it looks at what happens after rituximab and they recon that cladribine is the next most cost effective drug. People getting rituximab switch after side effects such as infections…
Tweet I have a bit of a laugh at the risk factor for MS of the week,which surfaces in this or that rag each week, This week we had a new risk factor and that is food processed but here in another one and that…
The other day, I walked into a room and stopped. Not because I needed something but because I couldn’t remember why I was there. Does this ever happen to you? Just a moment in the kitchen trying to remember what we thought we said we…
Tweet Immune response to EBV may control what the outcome is in relation to the infection, whether it is cancer or autoimmunity. I am sorry I don’t have the time or inclination to break this down further. Kamitaki N, Tang D, McCarroll SA, Loh PR.…
The European Medicines Agency (EMA) has granted PRIME designation to Oculis‘ experimental treatment privosegtor for optic neuritis, a condition commonly seen in people with multiple sclerosis (MS). Optic neuritis, marked by inflammation of the optic nerve that carries signals between the eyes and the brain,…
Tweet Personalized medicine has been a mantra for some years but in many cases this is just a pipe-dream. Personalization means screening to do selection and this equates to cost. It also takes time. Any screening is typically borne by the manufacturer. e.g., who pays…